Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077015

« Back to Dashboard

NDA 077015 describes SULFACETAMIDE SODIUM, which is a drug marketed by Fougera Pharms, Perrigo Co Tennessee, Taro, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Pharmafair, and Sandoz Inc, and is included in twelve NDAs. It is available from eighteen suppliers. Additional details are available on the SULFACETAMIDE SODIUM profile page.

The generic ingredient in SULFACETAMIDE SODIUM is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.

Summary for 077015

Tradename:	SULFACETAMIDE SODIUM
Applicant:	Fougera Pharms
Ingredient:	sulfacetamide sodium
Patents:	0
Therapeutic Class:	Antibacterials
Formulation / Manufacturing:	see details

Pharmacology for NDA: 077015

Ingredient-type	Sulfonamides

Medical Subject Heading (MeSH) Categories for 077015

Anti-Infective Agents, Local
Anti-Infective Agents, Urinary

Suppliers and Packaging for NDA: 077015

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SULFACETAMIDE SODIUM	sulfacetamide sodium	LOTION;TOPICAL	077015	ANDA	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	0168-0382	N	0168-0382-04
SULFACETAMIDE SODIUM	sulfacetamide sodium	LOTION;TOPICAL	077015	ANDA	Physicians Total Care, Inc.	54868-6225	E	54868-6225-0

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	LOTION;TOPICAL			Strength	10%
Approval Date:	Nov 17, 2006	TE:	AB	RLD:	No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi

Cantor Fitzgerald

Boehringer Ingelheim

US Department of Justice

Covington

Teva

US Army

UBS

Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.